Identification | Back Directory | [Name]
S,S-Atorvastatin | [CAS]
501121-34-2 | [Synonyms]
S,S-Atorvastatin 3S,5S-Atorvastatin Sodium Atorvastatin EP Impurity E S,S-Atorvastatin Sodium Salt (3S,5S)-Atorvastatin Sodium Salt Atorvastatin USP Related CoMpound E (bS,dS)-2-(4-Fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δS)- (S,dS)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium (βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid SodiuM | [Molecular Formula]
C33H34FN2NaO5 | [MOL File]
501121-34-2.mol |
Hazard Information | Back Directory | [Chemical Properties]
White Solid | [Uses]
A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia |
|
|